Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.
J Clin Oncol
; 37(34): 3291-3299, 2019 12 01.
Article
in En
| MEDLINE
| ID: mdl-31609651
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, B-Cell
/
Drug Resistance, Neoplasm
/
Antibodies, Monoclonal, Humanized
/
Antineoplastic Agents, Immunological
/
Mediastinal Neoplasms
/
Neoplasm Recurrence, Local
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
/
America do sul
/
Europa
Language:
En
Journal:
J Clin Oncol
Year:
2019
Document type:
Article
Affiliation country:
Country of publication: